Sign In

David LeDuc

Director of Oncology Patient Affairs

David LeDuc is an accomplished leader in the non-profit and philanthropic sectors, known for his strategic planning, marketing, operational excellence, and fundraising success. His personal experiences have driven his passion for cancer advocacy and organizational vision. Currently, as the Associate Director of Global Advocacy at AstraZeneca, he focuses on stakeholder relationships, advocating for patients, and integrating patient voices into company initiatives. David values leadership grounded in kindness, compassion, and humor, balancing work with family time and outdoor activities like biking. He holds a degree in Non-Profit/Public/Organizational Management from the University of Illinois at Chicago, and has held various significant roles in organizations such as AstraZeneca, GO2 Foundation for Lung Cancer, and the American Cancer Society.

Highlights

May 17 · linkedin

My mentor Bonnie Addario would regularly say, "if it is good for patients we have an obligation to do it" and it has been a guiding mantra for much of my career. I am so proud and humble to have that work, done only through the blessing of amazing partners and teams, recognized by PM360. https://lnkd.in/ezppj9m4

Mar 14 · linkedin

I am immensely proud to share this new video resource for people recently diagnosed with lung cancer.   This under 30-minute video takes viewers through the initial steps of a lung cancer diagnosis and outlines, as simply as possible, some of the terms and information they may encounter. For example, what is the difference between small cell and non-small cell lung cancer? Who are the medical specialists that may be included on their multidisciplinary care team? What is a multidisciplinary care team?   I have been thinking about a resource like this one for a long time – both as someone who has worked in the lung cancer space for over a decade and as someone who has felt first-hand the helplessness of trying to navigate the complexities and emotions of a close family member’s cancer diagnosis.   There is a wealth of resources available to patients with lung cancer and this one does not replace them. My hope is that this video will empower newly diagnosed patients with the knowledge to navigate the lung cancer landscape and the confidence to ask questions about their own care along the way.   You can watch the full-length video here [https://lnkd.in/euXTWg52] and view it in chapters here [https://lnkd.in/e-b-xQCc]. Please share with anyone you think may benefit from this information.   [The Lung Cancer Patient Navigation Video was produced through the Lung Ambition Alliance and funded by AstraZeneca.]

Related Questions

What are David LeDuc's main responsibilities at AstraZeneca?
How has David LeDuc's career evolved over the years?
What specific initiatives has David LeDuc led in global oncology policy?
What are some notable achievements of David LeDuc in patient advocacy?
How does David LeDuc contribute to health equity at AstraZeneca?
David LeDuc
David LeDuc, photo 1
David LeDuc, photo 2
Add to my network

Experience

Director of Oncology Patient Affairs at AstraZeneca (April 2020 - Present)
Chief Growth Officer at GO2 Foundation for Lung Cancer (April 2019 - April 2020), Executive Director at GO2 Foundation for Lung Cancer (June 2016 - April 2019), Senior Director of Strategic Alliances at Addario Lung Cancer Medical Institute (July 2015 - June 2016)

Education

University of Illinois at Chicago, Non-Profit/Public/Organizational Management

Location

Frederick, Maryland, United States